Navigation Links
iCAD to Present at America's Growth Capital 4th Annual Emerging Growth Conference
Date:9/12/2007

NASHUA, N.H., Sept. 12 /PRNewswire-FirstCall/ -- iCAD, Inc. (Nasdaq: ICAD), an industry-leading provider of Computer-Aided Detection (CAD) solutions for the early identification of cancer, today announced that Ken Ferry, President and Chief Executive Officer of iCAD, will be presenting at the America's Growth Capital 4th Annual Emerging Growth Conference on Thursday, September 20th at 12:00 p.m. (Eastern Daylight Time) at the Sheraton Boston.

The presentation will be webcast live and archived for replay on the "Investors" section of the Company's Web site at http://www.icadmed.com.

An audio webcast of the presentation will also be available after the conference at http://www.wsw.com/webcast/agc6/icad/.

About iCAD, Inc.

iCAD, Inc. (Nasdaq: ICAD) is an industry-leading provider of Computer-Aided Detection (CAD) solutions that enable healthcare professionals to better serve patients by identifying pathologies and pinpointing cancer earlier. iCAD offers a comprehensive range of high-performance, upgradeable CAD systems for the high, mid and low volume mammography markets. iCAD is entrusted with the task of early cancer detection by over one thousand women's healthcare centers worldwide. For more information, call +1 877 iCADnow or visit http://www.icadmed.com.

For iCAD, contact Darlene Deptula-Hicks, EVP and CFO at 603-882-5200 x7944 or via email at ddeptula@icadmed.com

For iCAD Investor Relations, contact Anne Marie Fields of Lippert/Heilshorn & Associates at 212-838-3777 x6604 o
'/>"/>

SOURCE iCAD, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. Surgeons Presented Guidelines For Postoperative Atrial Fibrillation
2. Researchers Present Ways To Reduce The Risk Of Dementia
3. Researchers Present Data Regarding The Efficiency Of Herbs
4. Critically Ill Patients More At Risk Of Infection If Glucose Is Present In Their Lung Secretions
5. Ovarian Cancer Presents ‘Target Symptoms’ Six Months Before Diagnosi
6. Drug Reactions First Present Themselves In The Mouth
7. Reminiscing Into The Past Makes You Dissatisfied With The Present
8. Living In The Past Indicates Dissatisfaction With Present
9. Movies Represent Coma In A Wrong Way
10. Onchocerciasis: Presentation And Treatment
11. Researchers Warn That Routine Physical Examination Could Miss Breech Presentation
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... Sir Fazle ... annual World Food Prize today. Sir Fazle has been recognised for his outstanding contribution ... , Ambassador Ken Quinn, President of the World Food Prize Foundation, announced this ...
(Date:7/1/2015)... (PRWEB) , ... July 01, 2015 , ... ... retail, long term care, specialty, combo, and compounding pharmacy operations, announces the most ... to the Cardinal Health RBC event at the Venetian Las Vegas, ...
(Date:7/1/2015)... ... 2015 , ... The Collaborative for Children and Families (CCF) announced that it ... allow CCF to improve quality of care and save costs for the child welfare ... many changes in New York’s Medicaid system. Experts agree that children need thorough solutions ...
(Date:7/1/2015)... ... 2015 , ... Did you know that infertility in men is more common ... Advanced Fertility Center of Texas (AFCT) would like to talk about some natural ways ... considered to be a “woman’s issue,” male fertility factors can play a role in ...
(Date:7/1/2015)... Florida (PRWEB) , ... July 01, 2015 , ... ... for society,” said lead author Lisa Stolzenberg, a Professor in FIU’s School of ... juveniles aged 12 to 17 years who participated in the National Survey on ...
Breaking Medicine News(10 mins):Health News:Sir Fazle Hasan Abed Receives World Food Prize 2Health News:Sir Fazle Hasan Abed Receives World Food Prize 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 2Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 3Health News:Pharmacy Software Vendor, SuiteRx IPS, Officially Introducing Newly Appointed CEO at Cardinal Health Event in Las Vegas, Nevada 4Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 2Health News:The Collaborative for Children and Families Receives a Grant From The New York Community Trust to Build Capacity for Comprehensive Child Welfare 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 2Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 3Health News:Male Fertility: Improve Testosterone and Fertility With Natural Approaches 4Health News:Researchers find that medical marijuana laws increase recreational marijuana use among juveniles 2
... Medivation, Inc.,(Nasdaq: MDVN ) today announced that ... at Cowen and Company,s 28th Annual Health,Care Conference on ... The,Boston Marriott Copley Place in Boston., Dr. Hung ... programs for Dimebon(TM) for Alzheimer,s and Huntington,s,diseases and MDV3100 ...
... Upcoming Federal Mandates, PORTLAND, Ore., March ... generation healthcare connectivity solutions, today announced that,Boston ... as its enterprise ePrescribing solution. This purchase, ... BMC prescribers to securely send,prescriptions from within ...
... of the Company,s, Acquisition Pipeline Gives Management Reason to Remain ... ... SAN JOSE, Calif., March 13 Pet DRx,Corporation ("Pet DRx" or ... and specialized services to companion,animals, today affirmed its 2008 guidance, noting ...
... Execution of Partnership Strategy Provides Nearly $450 Million ... and Committed Cash * 2008 Projected Net Operating Loss Less ... than $450 Million * Conference Call Webcast Thursday, March 13, 08:30 a.m. EDT ... http://www.isispharm.com , CARLSBAD, Calif., March 13 ...
... combination therapy VELCADE, melphalan and prednisone, reported a 32 percent complete ... ... years --, CAMBRIDGE, Mass., March 13 Millennium,Pharmaceuticals, Inc. (Nasdaq: ... Phase I/II clinical trial of the combination therapy,VELCADE, melphalan and prednisone ...
... 13 Echo Therapeutics,(OTC Bulletin Board: ECTE) ... of the Symphony(TM) tCGM System, a novel, ... at the,Tufts Medical Center in Boston, Massachusetts ... to provide patients with diabetes and healthcare,professionals ...
Cached Medicine News:Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 2Health News:Boston Medical Center Meets Prescription Challenges With Kryptiq ePrescribing Solution 3Health News:Pet DRx Affirms 2008 Guidance 2Health News:Pet DRx Affirms 2008 Guidance 3Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 2Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 3Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 4Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 5Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 6Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 7Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 8Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 9Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 10Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 11Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 12Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 13Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 14Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 15Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 16Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 17Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 18Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 19Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 20Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 21Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 22Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 23Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 24Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 25Health News:Isis Reports Financial Results and Highlights for Fiscal year 2007 26Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 2Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 3Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 4Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 5Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 6Health News:Publication of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As a Standard of Care In Newly Diagnosed Multiple Myeloma Patients 7
(Date:7/1/2015)... 2015 The Coalition of State Rheumatology ... regional professional rheumatology societies, today released the findings ... perceptions of biosimilars and the potential impact of ... Biosimilars are medicines that are highly similar, but ... different from generic medications in that it is ...
(Date:7/1/2015)... 2015 Jazz Pharmaceuticals plc (Nasdaq: JAZZ ) ... presentation at the Cantor Fitzgerald Healthcare Conference in ... Russell Cox , executive vice president and chief operating ... business and financial update on Wednesday, July 8, 2015 at ... A live audio webcast of the presentation may be accessed ...
(Date:7/1/2015)... 2015 ContraVir Pharmaceuticals, Inc. (NASDAQ: CTRV ... commercialization of targeted antiviral therapies, announced today that it ... taking place in New York, NY ... Hotel. James Sapirstein , Chief ... business during his live presentation and will be available ...
Breaking Medicine Technology:Survey Of Rheumatologists Nationwide Regarding Biosimilars Highlights Need For More Robust FDA Standards 2Jazz Pharmaceuticals to Present at Cantor Fitzgerald Healthcare Conference on July 8 2ContraVir to Present at Cantor Fitzgerald Inaugural Healthcare Conference 2
... HILLS, Calif., Sept. 15, 2011 HealthTech Capital, a ... emerging HealthTech market, announced today that it has closed ... from HealthTech Capital members in a Series B syndicated ... while Niveus Medical received $600,000 in a Series A ...
... Sept. 15, 2011 CarePoint Partners (CarePoint), a leading ... that it has acquired Mountain State Infusion Services (Mountain ... 14th acquisition in less than four years. CarePoint now ... and is one of the largest independent infusion therapy ...
Cached Medicine Technology:HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market 2HealthTech Capital Announces Two New Investments in the Emerging HealthTech Market 3CarePoint Partners Expands Coverage in the Ohio Valley Region with Acquisition of Mountain State Infusion Services 2
Inquire...
Inquire...
... anti-reflux valve is enclosed in ... prevents the valve from being ... sitting or reclining positions. The ... interference free ensuring uninterrupted flow ...
... valve is enclosed in a ... the valve from being accidentally ... or reclining positions. The valve ... free ensuring uninterrupted flow and ...
Medicine Products: